Stock Rating Downgrade
During the last several trading days the Value Trend Rating for Novo Nordisk A/S (NYSE: NVO) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Novo Nordisk A/S (NYSE: NVO) stock closed at $88.08 on 2/21/25 after a very large increase of 5.2%. Moreover, this advance was accompanied by unusually high trading volume at 157% of normal. The stock has risen 7.7% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Novo Nordisk A/S has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Novo Nordisk A/S has a good Appreciation Score of 79 but a very low Power Rating of 5, with the Negative Value Trend Rating the result.
Be the first to comment